(Q33956247)

30 July 2017

1 reference

title

Improving vaccine performance with adjuvants (English)

1 reference

30 July 2017

1 reference

Vogel FR

1

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 June 2000

1 reference

Clinical Infectious Diseases

30 July 2017

published in

1 reference

30 July 2017

volume

30 Suppl 3

1 reference

30 July 2017

page(s)

S266-70

1 reference

Studies on the O antigen of Salmonella typhosa. V. Enhancement of antibody response to protein antigens by the purified lipopolysaccharide

30 July 2017

cites work

1 reference

Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives

21 January 2018

1 reference

Comparison of adjuvant activities of aluminium phosphate, calcium phosphate and stearyl tyrosine for tetanus toxoid

21 January 2018

1 reference

CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity

21 January 2018

1 reference

Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems

21 January 2018

1 reference

LT(R192G), a non-toxic mutant of the heat-labile enterotoxin of Escherichia coli, elicits enhanced humoral and cellular immune responses associated with protection against lethal oral challenge with Salmonella spp.

21 January 2018

1 reference

Modulation of expression of class II MHC and CD40 molecules in murine B cells by various muramyl dipeptides.

21 January 2018

1 reference

Efficacy of inactivated whole HIV-2 vaccines with various adjuvants in cynomolgus monkeys

21 January 2018

1 reference

Dendritic cells internalize vaccine adjuvant after intramuscular injection

21 January 2018

1 reference

Clinical and immunologic responses to human immunodeficiency virus (HIV) type 1SF2 gp120 subunit vaccine combined with MF59 adjuvant with or without muramyl tripeptide dipalmitoyl phosphatidylethanolamine in non-HIV-infected human volunteers

21 January 2018

1 reference

Enhancement of humoral response against human influenza vaccine with the simple submicron oil/water emulsion adjuvant MF59.

21 January 2018

1 reference

Adjuvants--a balance between toxicity and adjuvanticity

21 January 2018

1 reference

Vaccinating guinea pigs with recombinant glycoprotein D of herpes simplex virus in an efficacious adjuvant formulation elicits protection against vaginal infection

21 January 2018

1 reference

Induction of sustained and elevated immune responses to weakly immunogenic synthetic malarial peptides by encapsulation in biodegradable polymer microspheres

21 January 2018

1 reference

Adjuvants influence the quantitative and qualitative immune response in BALB/c mice immunized with respiratory syncytial virus FG subunit vaccine

21 January 2018

1 reference

Increasing the immunogenicity of a trivalent influenza virus vaccine with adjuvant-active nonionic block copolymers for potential use in the elderly

21 January 2018

1 reference

Poly[di(carboxylatophenoxy)phosphazene] (PCPP) is a potent immunoadjuvant for an influenza vaccine

21 January 2018

1 reference

Molecular adjuvants and immunomodulators: new approaches to immunization

21 January 2018

1 reference

Interleukin 2 acts as an adjuvant to increase the potency of inactivated rabies virus vaccine

21 January 2018

1 reference

The adjuvant effect of interleukin-12 in a vaccine against Leishmania major.

21 January 2018

1 reference

Liposome-mediated cytoplasmic delivery of proteins: an effective means of accessing the MHC class I-restricted antigen presentation pathway

21 January 2018

1 reference

Priming for virus-specific CD8+ but not CD4+ cytotoxic T lymphocytes with synthetic lipopeptide is influenced by acylation units and liposome encapsulation

21 January 2018

1 reference

Cytotoxic T lymphocyte responses to a liposome-adjuvanted influenza A virus vaccine in the elderly

21 January 2018

1 reference

Adjuvants: current status, clinical perspectives and future prospects

21 January 2018

1 reference

A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules

21 January 2018

1 reference

Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues

21 January 2018

1 reference

Structure and function of human and murine receptors for IgG.

21 January 2018

1 reference

Paracrine cytokine adjuvants in cancer immunotherapy

21 January 2018

1 reference

Adjuvant action of cholera toxin and pertussis toxin in the induction of IgA antibody response to orally administered antigen.

21 January 2018

1 reference

Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/313883

1 reference

30 July 2017

1 reference